Top compounds associated with response to MEF2B


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0001
mRNA NVP-BEZ235 CTRPv2 pan-cancer AAC 0.17 0.0001
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA Crizotinib CTRPv2 pan-cancer AAC -0.12 0.0003
mRNA CIL41 CTRPv2 pan-cancer AAC 0.18 0.0003
mRNA OSI-906 CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA Zebularine CTRPv2 pan-cancer AAC -0.12 0.0005
mRNA ruxolitinib CTRPv2 pan-cancer AAC -0.12 0.0005
Download CSV